Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on August 11, 2026

Aug. 11, 2026

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

Aug. 11, 2026

Mobia Medical Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Indeterminate GlobeNewswire

Aug. 11, 2026

Five Reputable Gaming Chair Manufacturers in China 2026: Advancing Ergonomic Seating Solutions

Indeterminate EIN Presswire

Aug. 11, 2026

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire

Aug. 11, 2026

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Indeterminate GlobeNewswire

Aug. 11, 2026

IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy

Indeterminate GlobeNewswire

Aug. 11, 2026

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire

Aug. 11, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 11, 2026

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Indeterminate GlobeNewswire

Aug. 11, 2026

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Greystone Capital Advisors Arranges $103 Million Bridge Loan for 864 Unit Texas Multifamily Portfolio

Indeterminate GlobeNewswire

Aug. 11, 2026

ASHA Names 2026 Media Champion Award Recipients

Indeterminate GlobeNewswire

Aug. 11, 2026

Rampart Withdraws Appeal of USPTO’s Invalidation Decision

Indeterminate GlobeNewswire

Aug. 11, 2026

Five Years of Unprecedented Growth: TimelyCare Redefines Student Well-Being

Indeterminate GlobeNewswire

Aug. 11, 2026

Kratom Bird Strengthens Its Online Presence for Customers Looking to Buy Kratom UK

Indeterminate GlobeNewswire

Aug. 11, 2026

NovelMed Advances NM5072 for Multiple Ocular Disorders

Indeterminate GlobeNewswire